Drug . | Peripheral neuropathic pain NNT . | Central neuropathic pain NNT . | Mixed neuropathic pain NNT . | NNH . |
---|---|---|---|---|
Antidepressants: TCAD SSRI SNRI Combined | 2.1–2.8 6.8 5.5 3.3 | 4.0 - - 4.0 | - - - 1.6 | 14.7 - - 16.7 |
Anticonvulsant drugs: Phenytoin Carbamazepin GBP and PGB Lamotrigine Valproate Topiramate Combined | 2.1 2.3 3.9–4.6 4.0–5.4 2.1–2.4 7.4 4.2 | - - - - - - - | - - - - - - 10.0 | - - - - - 6.3 10.6 |
Opioids: Strong opioids Tramadol | 2.3–3.0 3.5–4.8 | - - | 2.1 - | 17.1 9.0 |
NMDA antagonists: Dextromethorphan | 2.5–3.4 | - | - | 8.8 |
Antiarrhythmics: Mexiletine Topical lignocaine | 2.2–7.8 4.4 | - - | - - | - - |
Cannabinoids | - | 3.4 | 9.5 | - |
Topical Capsaicin | 3.2–11.0 | - | - | 11.5 |
Drug . | Peripheral neuropathic pain NNT . | Central neuropathic pain NNT . | Mixed neuropathic pain NNT . | NNH . |
---|---|---|---|---|
Antidepressants: TCAD SSRI SNRI Combined | 2.1–2.8 6.8 5.5 3.3 | 4.0 - - 4.0 | - - - 1.6 | 14.7 - - 16.7 |
Anticonvulsant drugs: Phenytoin Carbamazepin GBP and PGB Lamotrigine Valproate Topiramate Combined | 2.1 2.3 3.9–4.6 4.0–5.4 2.1–2.4 7.4 4.2 | - - - - - - - | - - - - - - 10.0 | - - - - - 6.3 10.6 |
Opioids: Strong opioids Tramadol | 2.3–3.0 3.5–4.8 | - - | 2.1 - | 17.1 9.0 |
NMDA antagonists: Dextromethorphan | 2.5–3.4 | - | - | 8.8 |
Antiarrhythmics: Mexiletine Topical lignocaine | 2.2–7.8 4.4 | - - | - - | - - |
Cannabinoids | - | 3.4 | 9.5 | - |
Topical Capsaicin | 3.2–11.0 | - | - | 11.5 |
Pooled data, adapted from Finnerup et al. (2005)
Abbreviations: GBP: gabapentin; NNT: number needed to treat (see text for explanation); NNH: number needed to harm (see text for explanation); PGB: pregabalin; SNRI: selective noradrenaline and serotonin re-uptake inhibitors; SSRI: selective serotonin re-uptake inhibitors; TCAD: tricyclic antidepressant drugs
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.